Pre-Menopause, Menopause and Beyond Volume 5: Frontiers in Gynecological Endocrinology /

This volume represents an up-to-date overview on pre-Menopause and Menopause, with their respective clinical implications and therapies. The aim is to clarify possible doubts and clinical approaches to this particular period in a woman's life and how to face it, both offering solutions to actua...

Celý popis

Uloženo v:
Podrobná bibliografie
Médium: Elektronický zdroj E-kniha
Jazyk:angličtina
Vydáno: Cham : Springer International Publishing, 2018.
Vydání:1st ed. 2018.
Edice:ISGE Series,
Témata:
Gynecology .
Endocrinology .
Reproductive medicine.
ISBN:9783319635408
ISSN:2197-8735
On-line přístup: Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Obsah:
  • Part I Menopause: symptoms and neuroendocrine impact Intracrinology made menopause possible
  • From menopause to aging: endocrine and neuroendocrine biological changes
  • Brain impact of sex steroids withdrawall of the menopause
  • Climacteric symptoms: importance and management
  • Part II Fertility 2016 IMS Recommendations on women's midlife health, "POI" and menopause hormone therapy (MHT)
  • Female infertility and autoimmunity
  • Is IVF/ICSI/ET reasonable beyond the female age of 40 years?
  • IVF: new developments in patient tailored ovarian stimulation
  • Oocyte donation in peri-menopausal and menopausal women
  • Part III Thyroid disorders, polycystic ovary and metabolic syndrome Thyroid disorders in climacteric women
  • Thyroid function and pregnancy outcome after ART: what is the evidence?
  • PCOS: implications of cardio-metabolic dysfunction
  • Why Metformin is so important for prevention and treatment in climacteric women?
  • Metabolic changes during menopausal trans ition
  • Weight and body composition management after menopause
  • Part IV Bone and cardiovascular impact Healthy bones after menopause - what has to be done?
  • The effect of menopause and HRT on coronary heart disease
  • How to prevent cardiovascular disorders: influence of gonadal steroids on the heart
  • Part V Benign breast diseases, BRCA mutation and breast cancer Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other high risk women)
  • Benign breast disease during women's life
  • Treatment of menopausal symptoms in breast cancer survivors
  • Myo-inositol and Inositol Hexaphosphate (IP6) in the treatment of breast cancer
  • Part VI Menopause symptoms: the therapies The true risks of hormone replacement therapy
  • Menopausal hormone therapy customization
  • Vulvovaginal atrophy (VVA) and Genitourinary Syndrome of Menopause (GSM): Advances in management
  • Menopause symptoms: new treatment options
  • Intravaginal DHEA for the treatment of vaginal atrophy closest to physiology
  • Part VII Surgical challenges after menopause: problems and solutions Bladder dysfunction and urinary incontinence after the menopause: hormones, drugs or surgery?
  • When is ovarectomy and when tubectomy indicated at necessary hysterectomies beyond the reproductive age?
  • Pelvic floor reconstructive surgery in ageing women: tailoring the treatment to each woman's needs.

Podobné jednotky